May 7 (Bloomberg) — The owners of New England Compounding Pharmacy Inc., the drug supplier blamed for a nationwide meningitis outbreak that killed 64, agreed to a settlement providing $100 million toward compensation for victims.

The settlement, which includes money from insurers, will be implemented as part of a Chapter 11 plan, according to a filing by a trustee seeking approval of the accord in U.S. Bankruptcy Court in Boston. Criminal investigations involving company insiders, 322 lawsuits against the pharmacy and 3,300 claims from injury are continuing, according to the filing.

The pharmacy's tainted drugs, including a steroid administered by spinal injection, caused 64 deaths and 700 cases of meningitis, according to the Centers for Disease Control and Prevention. The company filed for bankruptcy protection in December 2012 as a result of the lawsuits.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Broker Regulation